Literature DB >> 11471103

Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old.

R K Syrjänen1, T M Kilpi, T H Kaijalainen, E E Herva, A K Takala.   

Abstract

To describe the natural course of nasopharyngeal carriage of Streptococcus pneumoniae and its relationship to acute otitis media (AOM), 329 Finnish children were followed from ages 2 to 24 months. In total, 3024 nasopharyngeal (NP) swabs (obtained at 10 scheduled healthy visits) and 2007 NP aspirates (obtained during respiratory infections) were cultured. Carriage during health increased gradually (9%-43%) with age. Within 4 age intervals, carriage was lower during health (13%-43%) than during respiratory infection without AOM (22%-45%). Higher proportions of positive samples were found during AOM (45%-56%), in particular during pneumococcal AOM (97%-100%). Antimicrobial treatment reduced carriage only temporarily. The most frequent NP serotypes were 6B, 6A, 11, 19F, and 23F. Both age and health status were important determinants of NP carriage of S. pneumoniae and these features should be considered carefully during analysis of carriage rates.

Entities:  

Mesh:

Year:  2001        PMID: 11471103     DOI: 10.1086/322048

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  84 in total

1.  Isolation of pneumococcal DNA from nasopharyngeal samples for real-time, quantitative PCR: comparison of three methods.

Authors:  Annika Saukkoriipi; Tarja Kaijalainen; Leena Kuisma; Anu Ojala; Maija Leinonen
Journal:  Mol Diagn       Date:  2003

2.  Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children.

Authors:  Anu Soininen; Maijastiina Karpala; Sirkka-Liisa Wahlman; Hannele Lehtonen; Helena Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

3.  Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.

Authors:  Andreas Kronenberg; Phillip Zucs; Sara Droz; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Detection and serotyping of Streptococcus pneumoniae from nasopharyngeal samples by PCR-based multiplex assay.

Authors:  Jaime Moreno; Elkin Hernández; Olga Sanabria; Elizabeth Castañeda
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  Using multilocus sequence data to define the pneumococcus.

Authors:  William P Hanage; Tarja Kaijalainen; Elja Herva; Annika Saukkoriipi; Ritva Syrjänen; Brian G Spratt
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

6.  Molecular characterization of non-penicillin-susceptible Streptococcus pneumoniae in Norway.

Authors:  Maren K R Sogstad; E Arne Høiby; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

7.  Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.

Authors:  Nina Ekström; Heidi Ahman; Jouko Verho; Jukka Jokinen; Merja Väkeväinen; Terhi Kilpi; Helena Käyhty
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.

Authors:  Irina V Alymova; Allen Portner; Toru Takimoto; Kelli L Boyd; Y Sudhakara Babu; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

9.  Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines.

Authors:  William P Hanage; Kari Auranen; Ritva Syrjänen; Elja Herva; P Helena Mäkelä; Terhi Kilpi; Brian G Spratt
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.

Authors:  Tera L McCool; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.